A Taiwanese review concluded toric IOLs are the preferred choice for astigmatism correction in cataract patients, with femtosecond laser-assisted astigmatic keratotomy (FSAK) serving as a viable alter
Rachel Mackenzlee Mayta lost her eye to retinoblastoma when she was just 18 months old. Determined to end the stigma against visible differences, she’s launched a range of funky prosthetics, including gold glittery ones, on TikTok.
Following a year-long UK pilot of a four-day working week, 51% of participating businesses confirmed they had made the model permanent, while 89% said they continued the policy after the pilot finishe
Results of an international study have demonstrated a shared immune surveillance mechanism between the brain and the eyes.
Ultra-widefield retinal imaging tech company Optos announced the dual milestone of installing 25,000 devices worldwide and the collection of 2,500 peer-reviewed studies spanning 235 disease states.
Biopharmaceutical company Telios Pharma has revealed positive topline results from its phase 2 study of TL-925, a first-in-class topical Bruton’s tyrosine kinase (BTK) inhibitor for individuals with dry eye disease (DED).
US researchers have found patients prescribed acetylcholinesterase inhibitors (AChEIs) to treat Alzheimer’s disease have a lower risk of developing age-related macular degeneration (AMD), compared wit
A blend of chokeberry, honeysuckle berry and bilberry extract improved near visual acuity and conjunctival hydration in presbyopic subjects, a Polish study found. The randomised, double-blind,
A new clinical study showed patients wearing Neurolenses had improved scores on a validated headache questionnaire. Using the Headache Impact Test (HIT) questionnaire, Neurolenses’ contoured-pr
Promising interim results from the phase 2 trial of Beacon Therapeutics' gene therapy to treat RP present a challenger to Luxturna.
Authors of a South Korean study found age-related macular degeneration (AMD) and certain cancers may share risk factors and pathogenic pathways.
Following the success of a University of Auckland-led pilot study examining castor oil as a treatment for dry eye disease, researchers are now looking for 90-plus participants for a larger, more robust study.